Nasdaq · Healthcare
RadNet, Inc. (RDNT)
As-reported financials and recent SEC filings for RadNet, Inc., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$2.04B
Net income
$-18.7M
Net margin
-0.9%
Diluted EPS
$-0.25
ROE
-1.4%
P/E (TTM)
—
Market cap
$4.78B
Debt / equity
0.8×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $2.04B | $1.83B | $1.62B | $1.43B | $1.32B |
| Gross profit | — | — | — | — | — |
| Operating income | $62.0M | $104.6M | $98.7M | $46.4M | $82.6M |
| Net income | $-18.7M | $2.8M | $3.0M | $10.7M | $24.7M |
| Diluted EPS | $-0.25 | $0.04 | $0.05 | $0.17 | $0.46 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
42026-06-22
View on EDGAR →1442026-06-18
View on EDGAR →42026-06-18
View on EDGAR →42026-06-18
View on EDGAR →1442026-06-16
View on EDGAR →42026-06-16
View on EDGAR →1442026-06-15
View on EDGAR →8-K2026-06-10
View on EDGAR →Go deeper on RDNT
Search RadNet, Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.